| Dir : /home/ithome/mail/new/ |
| Server: Linux host100322.itwesthosting.com 3.10.0-1160.144.1.el7.tuxcare.els4.x86_64 #1 SMP Tue Apr 7 08:40:40 UTC 2026 x86_64 IP: 144.91.64.173 |
| Dir : /home/ithome/mail/new/1774165600.M682034P7022.host100322.itwesthosting.com,S=14220,W=14439 |
Return-Path: <newsletter@enews.abnova.com.tw>
Delivered-To: ithome@host100322.itwesthosting.com
Received: from host100322.itwesthosting.com
by host100322.itwesthosting.com with LMTP
id sMMxKGCev2luGwAAp0YrwQ
(envelope-from <newsletter@enews.abnova.com.tw>)
for <ithome@host100322.itwesthosting.com>; Sun, 22 Mar 2026 08:46:40 +0100
Return-path: <newsletter@enews.abnova.com.tw>
Envelope-to: senka.rendulic@bolnica-lipik.hr
Delivery-date: Sun, 22 Mar 2026 08:46:40 +0100
Received: from smtp147097.spread6.net ([103.131.47.97]:40664 helo=smtp147097.spreadedm.net)
by host100322.itwesthosting.com with esmtps (TLS1.2) tls TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384
(Exim 4.96.2)
(envelope-from <newsletter@enews.abnova.com.tw>)
id 1w4DWA-0001v9-1i
for senka.rendulic@bolnica-lipik.hr;
Sun, 22 Mar 2026 08:46:40 +0100
Received: from WIN-U5BVQFM8LB2 (unknown [103.95.59.1])
by smtp147097.spreadedm.net (Postfix) with ESMTPA id 8E6A2610A8FF
for <senka.rendulic@bolnica-lipik.hr>; Sun, 22 Mar 2026 15:29:41 +0800 (HKT)
DKIM-Signature:v=1; a=rsa-sha1; c=relaxed/relaxed; d=enews.abnova.com.tw; s=intl;
q=dns/txt; h=From:Subject:Date:To; bh=PWqJ8wrjlkGZLp42/FfhxS1QKbA=;
b=H+oIH63wr1DG/4Vntr1zKsU7sABRBrNSnd6h3NmgsKgm4e77II+8DY1wsMYMe4lxW65EUl
qqfBqFTjzzEGhVlIdp3KUUClxjIHE7mFxQlo/7PzyikPcpVWT6HHVfwYq/YbFMB8I6GAnl/
GoUxXbgCBPBrdeKsfB0+wMppaaBUV4=;
DomainKey-Signature: a=rsa-sha1; c=simple; q=dns; d=enews.abnova.com.tw; s=intl;
h=From:To:Sender:Date:Subject:MIME-Version:Content-Type:X-Mailer:X-Spre
ad-CampaignId:X-Spread-SubscriberId:X-Spread-SpreaderId:X-Spread-Engine
-Build:List-Unsubscribe:Message-ID;b=Q2iYXLsdjyhTkYshZ9XUDl8tp8BiZYKe2Ruo+49opxVzv80JLvMHLTq4NDRssOs//OA4x
biTqbu7z9rD1cwGOMX0Xe+ZLB9QdJkbT0omlqtGOhIzj3L48Y0PFHkEwksVhyt9yype28iF
+zWmQKekE/eJqA5zMKJroXh+qLYzNHs=;
From: "Abnova" <newsletter@enews.abnova.com.tw>
To: "senka.rendulic@bolnica-lipik.hr" <senka.rendulic@bolnica-lipik.hr>
Sender: <newsletter@enews.abnova.com.tw>
Date: Sun, 22 Mar 2026 15:46:28 +0800
Subject: =?UTF-8?B?QWNjZWxlcmF0ZSBSTkEgUmVzZWFyY2ggd2l0aCBJbnRlZ3JhdGVkIElWVCBtUk5BLCBMTlAsIGFuZCBBbmFseXRpY2FsIFNlcnZpY2Vz?=
MIME-Version: 1.0
Content-Type: multipart/alternative;
boundary="_=aspNetEmail=_9c95768f1a274552bd3557be198a3f59"
X-Mailer: aspNetEmail ver 3.7.0.19
X-Spread-CampaignId: 8655295
X-Spread-SubscriberId: 217861858
X-Spread-SpreaderId: 85453
X-Spread-Engine-Build: 7.2.10.0
List-Unsubscribe: <mailto:abuse@mail.spread6.net?subject=sub/217861858/user/85453/campid/8655295/type/e>, <https://enews.abnova.com.tw/Unsubscribe.aspx?sub=217861858&user=85453&campid=8655295&type=e>
Message-ID: <WIN-U5BVQFM8LB25730d2d72bd8485798b402608099c8fe@WIN-U5BVQFM8LB2>
X-Spam-Status: No, score=0.7
X-Spam-Score: 7
X-Spam-Bar: /
X-Ham-Report: Spam detection software, running on the system "host100322.itwesthosting.com",
has NOT identified this incoming email as spam. The original
message has been attached to this so you can view it or label
similar future email. If you have any questions, see
root\@localhost for details.
Content preview: Bulk Orders for India's Thriving Biotech Industry Manage Preferences
| Unsubscribe
Content analysis details: (0.7 points, 5.0 required)
pts rule name description
---- ---------------------- --------------------------------------------------
0.0 URIBL_BLOCKED ADMINISTRATOR NOTICE: The query to URIBL was
blocked. See
http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block
for more information.
[URIs: abnova.com.tw]
0.0 RCVD_IN_VALIDITY_RPBL_BLOCKED RBL: ADMINISTRATOR NOTICE: The
query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[103.131.47.97 listed in bl.score.senderscore.com]
0.0 RCVD_IN_VALIDITY_CERTIFIED_BLOCKED RBL: ADMINISTRATOR NOTICE:
The query to Validity was blocked. See
https://knowledge.validity.com/hc/en-us/articles/20961730681243
for more information.
[103.131.47.97 listed in sa-accredit.habeas.com]
-0.0 SPF_PASS SPF: sender matches SPF record
0.7 MPART_ALT_DIFF BODY: HTML and text parts are different
0.1 MIME_HTML_ONLY BODY: Message only has text/html MIME parts
0.0 HTML_MESSAGE BODY: HTML included in message
-0.1 DKIM_VALID Message has at least one valid DKIM or DK signature
0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily
valid
-0.1 DKIM_VALID_AU Message has a valid DKIM or DK signature from
author's domain
0.0 MIME_HTML_ONLY_MULTI Multipart message only has text/html MIME
parts
X-Spam-Flag: NO
X-From-Rewrite: unmodified, forwarded message
--_=aspNetEmail=_9c95768f1a274552bd3557be198a3f59
Content-Type: text/html;
charset="us-ascii"
<!DOCTYPE html>
<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>Bulk Orders for India's Thriving Biotech Industry</title>
<style type="text/css">
body {
font-size: 12px;
-webkit-text-size-adjust: none;
}
table {
border-collapse: collapse;
mso-table-lspace: 0pt;
mso-table-rspace: 0pt;
border: 0;
}
span { margin: 0px; }
body {
width: 100% !important;
-webkit-text-size-adjust: 100%;
-ms-text-size-adjust: 100%;
margin: 0 auto;
padding: 0;
}
#body-layout {
margin: 0 auto;
padding: 0;
width: 100% !important;
line-height: 100% !important;
font-family: arial, sans-serif;
}
..page_wrap { margin: 0 auto; min-height: 200px; }
@media screen and (max-width:580px) {
.table_content { width: 100% !important; }
.mobile_hidden { display: none !important; }
.responsive-img { width: 100% !important; height: auto !important; }
}
</style>
</head>
<body bgcolor="#ffffff">
<div class="page_wrap">
<table width="100%" align="center" class="table_content" style="clear:both;margin: 0 auto;" bgcolor="#ffffff" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td align="center" style="font-family:Arial, Helvetica, sans-serif;">
<table width="710" align="center" class="table_content" bgcolor="#ffffff" border="0" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td>
<table width="100%" cellpadding="0" cellspacing="0" border="0" class="table_content" bgcolor="#004d9f" style="background-color: #004d9f;">
<tbody>
<tr>
<td style="font-size: 0; line-height: 0px;"><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8655295/linkid/1700861/Default.aspx" target="_blank"><img alt="Abnova" src="https://enews.abnova.com.tw/spreaderfiles/85453/8655295/639092783530265692/images/Abnova_Ad_Header_01.jpg" width="238" style="display: block;" border="0"></a></td>
<td style="font-size: 0; line-height: 0px;"><img alt="" src="https://enews.abnova.com.tw/spreaderfiles/85453/8655295/639092783530265692/images/Abnova_Ad_Header_02.jpg" width="472" style="display: block;" border="0"></a></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td>
<table id="___01" width="710" border="0" cellpadding="0" cellspacing="0">
<tr>
<td colspan="2">
<img src="https://enews.abnova.com.tw/spreaderfiles/85453/8655295/639092783530265692/images/IVT_mRNA_LNP_and_Analytical_Services_01.jpg" width="710"alt=""></td>
</tr>
<tr>
<td><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8655295/linkid/1700862/Default.aspx"><img src="https://enews.abnova.com.tw/spreaderfiles/85453/8655295/639092783530265692/images/IVT_mRNA_LNP_and_Analytical_Services_02.jpg" width="355"alt=""></a></td>
<td><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8655295/linkid/1700863/Default.aspx"><img src="https://enews.abnova.com.tw/spreaderfiles/85453/8655295/639092783530265692/images/IVT_mRNA_LNP_and_Analytical_Services_03.jpg" width="355"></a></td>
</tr>
<tr>
<td><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8655295/linkid/1700864/Default.aspx"><img src="https://enews.abnova.com.tw/spreaderfiles/85453/8655295/639092783530265692/images/IVT_mRNA_LNP_and_Analytical_Services_04.jpg" width="355"></a></td>
<td><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8655295/linkid/1700865/Default.aspx"><img src="https://enews.abnova.com.tw/spreaderfiles/85453/8655295/639092783530265692/images/IVT_mRNA_LNP_and_Analytical_Services_05.jpg" width="355"></a></td>
</tr>
<tr>
<td><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8655295/linkid/1700866/Default.aspx"><img src="https://enews.abnova.com.tw/spreaderfiles/85453/8655295/639092783530265692/images/IVT_mRNA_LNP_and_Analytical_Services_06.jpg" width="355"></a></td>
<td><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8655295/linkid/1700867/Default.aspx"><img src="https://enews.abnova.com.tw/spreaderfiles/85453/8655295/639092783530265692/images/IVT_mRNA_LNP_and_Analytical_Services_07.jpg" width="355"></a></td>
</tr>
</table>
</td>
</tr>
<tr>
<td>
<table width="100%" cellpadding="0" cellspacing="0" border="0" class="table_content" bgcolor="#004d9f" style="background-color: #004d9f;">
<tbody>
<tr>
<td style="font-size: 0; line-height: 0px;"><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8655295/linkid/1700861/Default.aspx" target="_blank"><img alt="" src="https://enews.abnova.com.tw/spreaderfiles/85453/8655295/639092783530265692/images/Abnova_Ad_Footer_01.jpg" width="208" style="display: block;" border="0"></a></td>
<td style="font-size: 0; line-height: 0px;"><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8655295/linkid/1700868/Default.aspx" target="_blank"><img alt="" src="https://enews.abnova.com.tw/spreaderfiles/85453/8655295/639092783530265692/images/Abnova_Ad_Footer_02.jpg" width="43" style="display: block;" border="0"></a></td>
<td style="font-size: 0; line-height: 0px;"><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8655295/linkid/1700869/Default.aspx" target="_blank"><img alt="" src="https://enews.abnova.com.tw/spreaderfiles/85453/8655295/639092783530265692/images/Abnova_Ad_Footer_03.jpg" width="37" style="display: block;" border="0"></a></td>
<td style="font-size: 0; line-height: 0px;"><a href="mailto:sales@abnova.com" target="_blank"><img alt="" src="https://enews.abnova.com.tw/spreaderfiles/85453/8655295/639092783530265692/images/Abnova_Ad_Footer_04.jpg" width="43" style="display: block;" border="0"></a></td>
<td style="font-size: 0; line-height: 0px;"><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8655295/linkid/1700870/Default.aspx" target="_blank"><img alt="" src="https://enews.abnova.com.tw/spreaderfiles/85453/8655295/639092783530265692/images/Abnova_Ad_Footer_05.jpg" width="39" style="display: block;" border="0"></a></td>
<td style="font-size: 0; line-height: 0px;"><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8655295/linkid/1700871/Default.aspx" target="_blank"><img alt="" src="https://enews.abnova.com.tw/spreaderfiles/85453/8655295/639092783530265692/images/Abnova_Ad_Footer_06.jpg" width="36" style="display: block;" border="0"></a></td>
<td style="font-size: 0; line-height: 0px;"><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8655295/linkid/1700872/Default.aspx" target="_blank"><img alt="" src="https://enews.abnova.com.tw/spreaderfiles/85453/8655295/639092783530265692/images/Abnova_Ad_Footer_07.jpg" width="36" style="display: block;" border="0"></a></td>
<td style="font-size: 0; line-height: 0px;"><a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8655295/linkid/1700873/Default.aspx" target="_blank"><img alt="" src="https://enews.abnova.com.tw/spreaderfiles/85453/8655295/639092783530265692/images/Abnova_Ad_Footer_08.jpg" width="41" style="display: block;" border="0"></a></td>
<td style="font-size: 0; line-height: 0px;"><img alt="" src="https://enews.abnova.com.tw/spreaderfiles/85453/8655295/639092783530265692/images/Abnova_Ad_Footer_09.jpg" width="227" style="display: block;" border="0"></td>
</tr>
</tbody>
</table>
</td>
</tr>
<tr>
<td align="right" style="font-size: 14px; font-family: arial; color: #666666; padding: 10px 0;">
<span style="line-height: 18px; font-family: arial, helvetica, sans-serif; font-size: 14px; color: #666666;">
<a href="https://enews.abnova.com.tw/t.aspx/subid/217861858/camid/8655295/linkid/1700874/Default.aspx" style="color: #666666; text-decoration: none;" target="_blank">Manage Preferences</a> |
<a href="https://enews.abnova.com.tw/Unsubscribe.aspx?sub=217861858&user=85453&campid=8655295&type=h" target="_blank" style="color: #666666; text-decoration: none;">Unsubscribe</a>
</span>
</td>
</tr>
</tbody>
</table>
</td>
</tr>
</tbody>
</table>
</div>
</body>
</html>
<img src="https://enews.abnova.com.tw//o.aspx/s/217861858/c/8655295" width="1" height="1" />
--_=aspNetEmail=_9c95768f1a274552bd3557be198a3f59--